http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106939333-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 |
| filingDate | 2016-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106939333-B |
| titleOfInvention | Application of the miRNA marker in the Cervical intraepitheliaI neoplasia reagent for preparing screening folic acid deficiency group |
| abstract | The present invention relates to a kind of genetic engineering and clinical medicine domain, application of specially a kind of miRNA marker in the Cervical intraepitheliaI neoplasia reagent for preparing screening folic acid deficiency group.A kind of application of miRNA marker in the Cervical intraepitheliaI neoplasia reagent for preparing screening folic acid deficiency group, the folic acid deficiency standard are no more than 10nmol/L, and the miRNA marker includes：MiRNA is 14；MiR 10a, miR 375, miR 23a, miR 18a, miR 6774, miR 21, miR 3613, miR 4730, miR 1247, miR 3607, miR 224, miR 30a, miR 30c, miR 196b.The reagent or kit can be used for checking 14 miRNA expressions in folic acid deficiency patient's cervical tissue.Suffer from CIN or even the risk of cervical carcinoma in order to analyze this types of populations. |
| priorityDate | 2016-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.